Mylan N.V. (NASDAQ: MYL), which has faced a plethora of lawsuits in the past over its EpiPen, is now being saddled with another lawsuit, although this time around the parties involved go beyond the company and the plaintiffs. EpiPen And Its Legal Tussle EpiPen, or an epinephrine auto injector is a medical device which is used to inject a measured dose of epinephrine through autoinjector …
A class action lawsuit has been filed against Mylan alleging the company violated consumer protection laws and the Racketeer Influenced and Corrupt Organization Act by upping the price of the epinephrine auto-injector. Amber Rainey, Christina Kollmeyer and Lisa Vogel filed the lawsuit April 3 in the U.S. District Court for the Western District of Washington. The plaintiffs claim …
Mylan CEO Heather Bresch holds up an EpiPen while testifying on Capitol Hill in Washington, Wednesday, Sept. 21, 2016, before the House Oversight Committee hearing on EpiPen price increases. AP Christina Kollmeyer’s son has a allergy that requires him to carry an EpiPen, the emergency auto-injecting devices available that can be used to treat severe allergic reactions. When Kollmeyer, who has …
Lawyers in Houston are representing consumers in the Midwest who have sued Mylan, the pharmaceutical company, for “deliberate and reprehensible price gouging” …
When Mylan ( $MYL ) quickly settled its Medicaid allegations a week ago with a $465 million payment, analysts and politicians predicted the company’s EpiPen trouble would be far from over. Now, that’s ringing true as the pharma faces a shareholder lawsuit pressing for damages from related share price drops. Bernstein Liebhard announced a class action suit claiming securities violations at Mylan …
Pomerantz LLP announces that a class action lawsuit has been filed against Mylan N.V. (“Mylan” or the “Company”) (NASDAQ: MYL ) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08000, is on behalf of a class consisting of all persons or entities who purchased …
“Close to a thousand” users of Mylan N.V.’s EpiPen have expressed interest in joining a class-action lawsuit alleging price-gouging, the FOX Business Network has learned. “We have probably close to 1,000 people that have reached out to us. Social media is unbelievable.
Mylan Specialty is giving schools around the country its EpiPen device to fight the severe allergic reaction called anaphylaxis. (Photo: Provided) A Cincinnati attorney has filed a class-action lawsuit against the maker of the EpiPen, calling the device’s 500-percent price increase in the last several years “immoral” and “nothing more than price-gouging.” The lawsuit filed Tuesday in Hamilton …
Cincinnati attorney Carl Lewis says he will become one of the first lawyers in the United States to file a class-action lawsuit against the makers of the EpiPen over skyrocketing costs Tuesday morning. The price of the EpiPen, a device designed to combat life-threatening allergic reactions, has climbed from about $100 in 2007 to $600 to $700 for a pack of two in 2016. The …
As the makers of EpiPen battle a firestorm surrounding price increases, a new federal lawsuit seeking class-action status argues that the company is engaging in price gouging by forcing consumers to buy the pens in packs of two. The lawsuit was filed Tuesday in the Eastern District of Michigan on behalf of …